VivoSeq
Other

Thoracoscopic Surgery

2

Pipeline Programs

5

Active Trials

1

Companies Involved

Thoracoscopic Surgery is an early-stage landscape with 2 programs across 1 company. The most active players are Fresenius Kabi Oncology Ltd..

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

62/100

Attrition Rate

24/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

21

clinical trials

Completed8 · 38%
Unknown status3 · 14%
Withdrawn3 · 14%
Recruiting3 · 14%
Not yet recruiting2 · 10%
Terminated2 · 10%

Trial Activity

21 trials

SPSIPB vs SAPB for Thoracoscopic Surgery
Completed·MMedipol University·N/A·NCT06546839·50 enrolled
Intrathecal Morphine for Thoracoscopic Surgery
Completed··Phase 4·NCT05588336·46 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)